Novo CEO pressed by Senate to chop costs of weight problems, diabetes medicine CEO Lars Fruergaard Jørgensen explained to lawmakers the company would look at new talks with insurers with regards to the list selling prices of Wegovy and copyright if they pledge to help keep the medicines on their https://ricardoumcsi.bloggazza.com/29940296/everything-about-healthcare-news